Griffithsin

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameGriffithsin
Drug Alias NameQ-GriffithsinQ-GRFTPC-6500
ClassificationBiologics
Mechanisms of ActionSARS-CoV-2 Spike glycoprotein receptor binding domain antagonists
TargetsSARS-CoV-2 Spike glycoprotein receptor binding domain
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute
Inactive CompaniesPopulation Council, Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipedia